Director's Messages

Director's Messages

Subscribe to Director's Messages: National Institute of Neurological Disorders and Stroke (NINDS)RSS

A New NIH Loan Repayment Program (LRP) will make LRP support available to virtually all clinician-scientists

(Tuesday, June 29, 2021)
Clinician-scientists, who understand diseases and disorders intimately due to their clinical training and practice, are critical to accomplishing the NINDS mission.

The Seventh Annual BRAIN Investigators Meeting Is Here!

(Monday, June 14, 2021)
From June 15-17, NIH will host the seventh annual Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative Investigators Meeting, with an exciting all-virtual format.

Funding Innovative Research: The NINDS Research Program Award (R35)

(Tuesday, June 8, 2021)
In addition to creativity, hard work and persistence, scientific discovery relies on researchers’ support to pursue critically important but difficult questions. This frequently requires long-term approaches and the ability to redirect experimental approaches as the evolving science dictates.

NINDS Releases New Five-Year Strategic Plan

(Wednesday, May 26, 2021)
In a wonderful opportunity to look ahead and steer the course and field of neuroscience research, I am happy to announce the new 2021-2026 NINDS Strategic Plan:

May is Stroke Awareness Month

(Wednesday, May 19, 2021)
May is Stroke Awareness Month, an opportunity to remember that despite amazing advances in research and clinical care, stroke continues to be the fifth leading cause of death and a leading cause of adult disability in the United States.

NINDS is committed to ending structural racism

(Thursday, March 4, 2021)
Inherent in the NINDS mission is that its goal of generating knowledge to reduce the burden of neurological disease should benefit all people. NIH has recently launched an agency-wide effort called the UNITE Initiative to end structural racism in biomedical research.

NINDS supports new initiative to understand long-term symptoms and promote recovery from COVID-19

(Wednesday, February 24, 2021)
Every day we are learning more about the effects of SARS-CoV-2 infection on the nervous system—in some cases detrimental effects that last far longer than the infection.

Enhancing and maintaining a culture of inclusive excellence: The NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program

(Friday, February 12, 2021)
Inherent in the mission of NIH is that biomedical research and its application can and should benefit all people.

New resources for large-scale ME/CFS research

(Friday, February 5, 2021)
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic and severe disease that, according to the CDC, affects up to 2.5 million Americans, many of whom have not been diagnosed. Active NINDS efforts are underway to seek a better understanding of ME/CFS in order to treat—and ultimately prevent—this disease.

Making HEADWAY on Inequities in Neurological Health

(Monday, January 11, 2021)
The term “HEADWAY” means moving forward or making progress, especially when circumstances make things slow or difficult. When it comes to health equity in neurological disorders, never has a term more accurately described a process.